The Association Between Oral Diseases and Cardiovascular Diseases: A Literature Review

Muhammad Ali Hussain

Abstract

Historically, medicine and dentistry have been treated as separate disciplines. However, modern scientific literature indicates that oral health and systemic cardiovascular health are closely connected. This literature review evaluates the association between common periodontal diseases (gingivitis and periodontitis) and major cardiovascular diseases (CVD), such as atherosclerosis, myocardial infarction, stroke, and hypertension.

Epidemiological evidence demonstrates a consistent statistical correlation between poor oral health and elevated cardiovascular risk [cite: 1, 2]. Proposed biological mechanisms to explain this link include transient bacteraemia facilitating direct bacterial invasion of blood vessels, indirect systemic inflammation leading to endothelial dysfunction, and autoimmune cross-reactivity via molecular mimicry [cite: 3, 4]. However, establishing a definitive causal relationship remains challenging due to shared confounding factors like smoking, diabetes, and socioeconomic status. Genetic analyses and clinical intervention studies suggest that periodontitis may act primarily as a marker of cumulative inflammatory risk rather than an independent direct cause of CVD [cite: 5, 6]. Ultimately, this review highlights the importance of interdisciplinary healthcare and suggests that maintaining optimal oral hygiene should be integrated into comprehensive cardiovascular preventive strategies.

Introduction

The oral cavity acts as a dynamic entry point to the human body, hosting a diverse and complex microbiome. For many years, localized conditions like gingivitis and periodontitis were viewed as separate from general medicine, with treatment focused primarily on local symptoms like bleeding gums and tooth loss. Today, however, research in ‘periodontal medicine’ increasingly suggests that chronic oral dysbiosis and inflammation can have systemic implications [cite: 7]. Among these connections, the possible link between oral health and the cardiovascular system has received significant attention.

Cardiovascular diseases are the leading cause of death globally. In 2021, they were responsible for around 20.5 million deaths, which represents more than a quarter of all global mortality [cite: 2, 8]. At the same time, severe periodontal disease is highly prevalent, affecting over one billion people worldwide [cite: 1]. Given that both pathologies involve chronic inflammatory processes and frequently occur in similar demographic groups, researchers have spent decades attempting to determine whether a direct biological link exists between them.

This literature review aims to explore this association objectively. It will explain the basic biology of these diseases, look at the epidemiological evidence connecting them, and discuss the biological mechanisms that might explain the link [cite: 9, 10]. It will also cover the limitations of current research, such as the problem of confounding factors, to show why correlation does not necessarily mean causation. Finally, it will discuss how closer teamwork between doctors and dentists could improve patient care in the future.

Overview of Oral Diseases

The oral conditions most frequently linked to systemic pathology are those affecting the periodontium. The periodontium consists of the supporting tissues of the dentition, including the gingiva, the periodontal ligament, the cementum, and the alveolar bone.

Periodontal disease typically begins as gingivitis, a highly prevalent and reversible inflammatory condition of the gingival margin. It is initiated by the accumulation of dental plaque, a complex bacterial biofilm,along the gumline. In the absence of regular mechanical plaque control, such as brushing and flossing, bacterial metabolic byproducts trigger a localized host immune response. This manifests clinically as erythema, oedema, and gingival bleeding [cite: 11]. Gingivitis can be completely resolved by thorough professional cleaning and improved home care.

If left untreated, gingivitis can develop into periodontitis in susceptible individuals. Periodontitis is a chronic, destructive inflammatory disease characterized by a dysbiotic shift in the oral microbiota, leading to the irreversible loss of the periodontal ligament and alveolar bone [cite: 12]. As these tissues break down, deep periodontal pockets form between the tooth and the gingiva. These pockets are highly anaerobic, providing an ideal environment for pathogenic Gram-negative bacteria to proliferate.

To standardize the diagnosis and classification of periodontitis globally, an updated classification framework was introduced in 2017 [cite: 11, 12]. The previous 1999 system, which divided the disease into “chronic” and “aggressive” forms, was replaced because biological evidence did not support them as distinct disease entities [cite: 12]. The updated framework classifies periodontitis using a multi-dimensional system of “Staging” and “Grading” [cite: 11, 12].

Classification Component

Definition

Key Clinical Indicators

Stage I — IV

Measures how severe the disease is and how complex it will be to treat.

Looks at attachment loss, bone loss on x-rays, pocket depths, and teeth lost to disease. Stage I is mild, while Stage IV is advanced disease that affects chewing [cite: 11, 12].

Grade A — C

Estimates the risk of the disease getting worse quickly.

Based on bone loss relative to age. Systemic factors like smoking and blood sugar control (in diabetes) heavily influence the grade [cite: 12].

This system is highly relevant to medical research because it officially recognises that systemic factors like diabetes and smoking affect oral health [cite: 11, 12].

Overview of Cardiovascular Diseases

Cardiovascular diseases (CVD) affect the heart and blood vessels. The most significant threat to global health in this category is atherosclerotic cardiovascular disease (ASCVD). This includes coronary artery disease (CAD), myocardial infarction, ischaemic stroke, and peripheral artery disease [cite: 9].

Atherosclerosis was historically conceptualized as a passive process involving lipid accumulation in the vessel walls. Current models, however, define it as a chronic, immune-mediated inflammatory disease [cite: 13, 14]. The pathogenesis initiates with endothelial dysfunction, which is damage to the delicate inner lining of the blood vessels. Factors such as toxins from cigarette smoke, mechanical stress from hypertension, or circulating inflammatory cytokines can injure the endothelium, increasing its permeability. This allows low-density lipoproteins (LDL) to enter the arterial wall, where they undergo oxidation [cite: 13, 15].

The host immune system recognises these oxidised lipids as foreign and recruits monocytes to the site of injury. These cells differentiate into macrophages and phagocytose the lipids, eventually transforming into lipid-laden “foam cells” [cite: 13, 15]. The accumulation of these foam cells forms an atheromatous plaque. If inflammation persists, proteolytic enzymes can weaken the plaque’s fibrous cap, making it susceptible to rupture. A rupture triggers immediate thrombus formation, which can acutely occlude blood flow. This occlusion may cause a myocardial infarction if it occurs in the coronary arteries, or an ischaemic stroke if it occurs in the cerebral vasculature [cite: 13].

Hypertension is another major form of CVD that physically damages blood vessels, accelerating the atherosclerotic process [cite: 9, 16]. Because low-grade chronic inflammation plays a central role in every stage of CVD, researchers have hypothesized that chronic oral infections, such as periodontitis, may act as systemic inflammatory triggers that promote cardiovascular events [cite: 7, 9].

Evidence Connecting Oral and Cardiovascular Diseases

The hypothesis that periodontal disease is associated with cardiovascular pathology is supported by substantial epidemiological data. Many observational studies have found a clear statistical link between periodontitis and various forms of ASCVD [cite: 9, 10].

A prominent Swedish case-control trial, the PAROKRANK study, compared 805 patients experiencing their first myocardial infarction with 805 age- and sex-matched healthy controls [cite: 3]. The investigators adjusted for nearly 100 potential confounding variables, including smoking habits, diabetes, and socioeconomic status. Even after this rigorous adjustment, the presence of periodontitis was found to be independently associated with an increased risk of a first heart attack [cite: 3].

This association is also observed in cerebrovascular events. The ARIC (Atherosclerosis Risk in Communities) study tracked over 10,000 stroke-free participants for a 15-year period [cite: 4]. The results demonstrated a graded trend, where severe periodontal disease was significantly associated with cardioembolic and thrombotic stroke subtypes [cite: 4]. Notably, regular dental care use was associated with a lower hazard of incident stroke [cite: 4]. These findings are supported by multiple systematic reviews and meta-analyses, which report that patients with periodontitis have a significantly higher relative risk of ischaemic stroke compared to periodontally healthy controls [cite: 17, 18].

A similar correlation has been documented with high blood pressure. Meta-analyses confirm that moderate-to-severe periodontitis is associated with a 49% increase in the odds of developing arterial hypertension [cite: 16, 19]. Patients with periodontal disease also consistently exhibit higher average systolic and diastolic blood pressure readings compared to those with healthy periodontal tissues [cite: 16, 19].

Study or Analysis

Cardiovascular Outcome

Key Findings

Methodological Adjustments & Notes

PAROKRANK Study [cite: 3]

First Myocardial Infarction

Periodontitis was associated with an increased risk of a first myocardial infarction.

Case-control design; adjusted for nearly 100 covariates (e.g. smoking, diabetes, socioeconomic status).

ARIC Study Analysis [cite: 4]

Incident Ischaemic Stroke

Severe periodontal disease was significantly associated with cardioembolic and thrombotic stroke subtypes.

Prospective 15-year cohort; regular dental care use was associated with a lower stroke hazard.

Hypertension Meta-Analysis [cite: 16, 19]

Arterial Hypertension

Moderate-to-severe periodontitis was associated with a 49% increase in the odds of hypertension.

Included 81 observational studies; patients with periodontitis exhibited higher mean systolic and diastolic blood pressure.

Proposed Biological Mechanisms

The biological plausibility of the periodontitis-CVD link has been explored through several pathways. Current research points to three main biological mechanisms: direct bacterial dissemination, systemic inflammation, and immune cross-reactivity [cite: 9, 10].

While all three mechanisms are biologically plausible, they do not possess equal levels of scientific support. Currently, the systemic inflammatory pathway has the strongest clinical evidence in humans, supported by randomized controlled trials showing that reducing oral inflammation directly improves endothelial function. In contrast, direct bacterial invasion and molecular mimicry are strongly supported by laboratory and animal models, but proving their active contribution in clinical settings remains more difficult.

Direct Bacterial Dissemination

The periodontal tissues are highly vascularised. In a patient with severe periodontitis, the total surface area of ulcerated pocket epithelium is estimated to be approximately 72 square centimetres, comparable to the palm of a human hand. Because this barrier is disrupted, mechanical manipulation from daily activities such as mastication or toothbrushing can translocate oral bacteria into the systemic circulation, a state known as transient bacteraemia [cite: 15, 20].

Once in the bloodstream, certain periodontal pathogens, particularly Porphyromonas gingivalis, can travel to distant sites. Indeed, both P. gingivalis DNA and viable bacterial cells have been recovered from human coronary and carotid atheromatous plaques [cite: 20, 21]. The virulence of P. gingivalis is partly mediated by fimbriae, which facilitate adherence to and invasion of endothelial cells [cite: 22]. Intracellularly, the pathogen may evade host immunological clearance, disrupt cellular homeostasis, and stimulate the expression of pro-inflammatory cytokines, potentially accelerating foam cell formation [cite: 15, 22]. Furthermore, the secretion of outer membrane vesicles (OMVs) and proteolytic enzymes known as gingipains can facilitate distal vascular damage independently of whole-cell translocation [cite: 23].

Systemic Inflammation and Endothelial Dysfunction

Even in the absence of direct bacterial invasion, persistent localized inflammation in the periodontium can induce a systemic acute-phase response. The host immune response to the dysbiotic subgingival biofilm generates high levels of pro-inflammatory cytokines, such as Interleukin-6 (IL-6) and C-reactive protein (CRP) [cite: 24]. These mediators circulate systemically, potentially impairing endothelial function by reducing the synthesis of nitric oxide, a key molecule required for vasodilation [cite: 25]. This endothelial dysfunction represents the earliest stage of atherogenesis [cite: 9, 26].

A prominent study by Tonetti and colleagues demonstrated this mechanism in a clinical setting. They evaluated endothelial function, via flow-mediated dilation (FMD) of the brachial artery, in 120 patients undergoing intensive periodontal therapy. Twenty-four hours post-treatment, patients exhibited a transient increase in systemic inflammatory markers and a corresponding decrease in FMD, likely reflecting acute bacteraemia induced by mechanical instrumentation. However, six months post-therapy, the resolution of periodontal inflammation was associated with a significant and sustained improvement in endothelial function compared to the control group [cite: 26, 27].

Molecular Mimicry

A third proposed mechanism involves an autoimmune-like cross-reactivity known as molecular mimicry. Under environmental stress, both bacterial and human cells produce highly conserved proteins called heat shock proteins (HSPs). When P. gingivalis enters the circulation, it expresses a bacterial heat shock protein called GroEL [cite: 28].

This cross-reactivity arises because prokaryotic GroEL shares significant structural homology with human Heat Shock Protein 60 (Hsp60), which is expressed on endothelial cells under cellular stress (such as that induced by shear stress or smoking) [cite: 28]. Consequently, antibodies raised against the bacterial pathogen may inadvertently target and damage the host vascular endothelium, accelerating the atherosclerotic process [cite: 28].

Contradictory Findings and Limitations

While the biological theories are plausible and the epidemiological links are consistent, it is essential to evaluate the literature critically. A fundamental scientific principle is that correlation does not imply causation.

The primary challenge in establishing a causal relationship is the abundance of shared confounding factors [cite: 29, 30]. Periodontitis and CVD share a highly similar risk profile. Individuals who smoke, consume diets high in saturated fats and sugars, have limited physical activity, or suffer from obesity and diabetes are highly susceptible to both conditions [cite: 29, 31]. Smoking, for instance, impairs endothelial function while simultaneously reducing gingival blood flow, masking early signs of gum disease while exacerbating deep tissue damage [cite: 32]. Similarly, poorly controlled diabetes triggers systemic hyper-inflammatory responses that destroy both periodontal tissues and microvascular networks [cite: 31, 32]. Consequently, it is difficult to determine whether periodontitis directly contributes to CVD progression or merely serves as a marker of a lifestyle predisposed to systemic inflammation.

To address this issue, researchers have utilized Mendelian randomisation (MR), a genetic epidemiological method that uses genetic variants as proxies for environmental exposures to evaluate causal pathways. Because genetic variants are randomly allocated at conception, they are not influenced by lifestyle confounders, simulating a natural clinical trial. Some large-scale MR studies have reported a lack of robust genetic evidence supporting a direct causal relationship between periodontitis and coronary artery disease or ischaemic stroke [cite: 6, 33]. Instead, pleiotropic analyses suggest a shared genetic architecture related to general inflammatory and metabolic pathways, such as the inflammation-metabolism axis [cite: 33, 34]. This indicates that the association may be mediated by common genetic liabilities rather than a simple, direct causal link.

Furthermore, interventional trials evaluating whether periodontal therapy can reduce major adverse cardiovascular events (MACE) have yielded inconsistent or inconclusive results. Although non-surgical periodontal therapy has been shown to improve surrogate markers of cardiovascular risk, such as endothelial function and systemic inflammatory mediators [cite: 24, 26], its efficacy in preventing hard clinical outcomes remains unproven. For example, the Periodontitis and Vascular Events (PAVE) pilot study, which evaluated secondary prevention in patients with established coronary heart disease, found no statistically significant difference in cardiovascular events between patients receiving protocol-directed periodontal therapy and those undergoing community care [cite: 5, 35].”

Clinical Implications

Despite the academic debate regarding direct causality, the established association between oral and systemic inflammation has significant clinical implications. International clinical guidelines have increasingly moved away from treating dentistry and medicine as isolated disciplines.

Following joint workshops, organizations such as the European Federation of Periodontology (EFP) and the World Heart Federation (WHF) released consensus guidelines [cite: 10]. The American Heart Association (AHA) has also highlighted periodontitis as an important risk marker for ASCVD [cite: 9]. These international bodies recommend that patients with periodontitis be informed of their potentially elevated risk for developing ASCVD [cite: 9, 10].

Dental professionals are encouraged to perform opportunistic screenings for cardiovascular risk factors. This includes compiling thorough medical histories, monitoring arterial blood pressure in the dental chair, and providing lifestyle counselling regarding smoking cessation and nutritional modifications [cite: 9]. Conversely, physicians and cardiologists are advised to screen patients for clinical signs of periodontal diseases, such as gingival bleeding, halitosis, or tooth mobility, and refer them for comprehensive dental evaluations [cite: 9, 10].

Although mechanical periodontal therapy can induce transient bacteraemia, current guidelines confirm that non-surgical instrumentation is safe for patients with established CVD, including those receiving antiplatelet or anticoagulant therapies, provided standard haemostatic protocols are maintained [cite: 10]. Resolving the chronic oral infection is considered far more beneficial to the patient’s systemic health than the minor, acute risks associated with dental procedures.

Future Directions for Research

To clarify whether a true causal relationship exists, further well-powered, multi-centre randomised controlled trials with extended follow-up periods are required. These investigations should focus on ‘hard’ clinical endpoints, such as the incidence of myocardial infarction and stroke, rather than relying solely on surrogate inflammatory or vascular biomarkers [cite: 5, 36].

Additionally, novel methodological approaches are needed to better isolate the independent effects of periodontitis from shared lifestyle confounders. Recent studies have begun to explore the role of “biological ageing” as a potential mediator. These investigations suggest that chronic systemic inflammation secondary to periodontitis may accelerate cellular biological ageing, which in turn could increase cardiovascular susceptibility [cite: 37]. Investigating these pathways and identifying specific pathogenic profiles within the oral microbiome will be essential for developing targeted preventive strategies.

Conclusion

In conclusion, the scientific literature demonstrates a consistent and independent association between periodontal diseases and cardiovascular diseases. Although a definitive causal relationship remains unproven due to substantial confounding by shared risk factors such as smoking and diabetes, the biological plausibility of the link is supported by pathways involving systemic inflammation, transient bacteraemia, and immune cross-reactivity. Periodontitis serves as a valuable clinical indicator of elevated systemic inflammatory risk. Consequently, maintaining optimal oral health through regular plaque control and professional care is an important component of general preventive medicine. Rather than viewing dental and medical health as separate disciplines, a more integrated, interdisciplinary approach between healthcare providers may enhance patient risk assessment and support overall cardiovascular health.

References

1. Hu M, Zhang R, Wang R, Wang Y, Guo J. Global, regional, and national burden of periodontal diseases from 1990 to 2021 and predictions to 2040: an analysis of the global burden of disease study 2021. Front Oral Health. 2025;6:1627746.
2. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982–3021.
3. Rydén L, Buhlin K, Ekstrand E, de Faire U, Gustafsson A, Holmer J, et al. Periodontitis Increases the Risk of a First Myocardial Infarction: A Report From the PAROKRANK Study. Circulation. 2016;133(6):576–583.
4. Sen S, Giamberardino LD, Moss K, Morelli T, Rosamond WD, Gottesman RF, et al. Periodontal Disease, Regular Dental Care Use, and Incident Ischemic Stroke. Stroke. 2018;49(2):355–362.
5. Offenbacher S, Beck JD, Moss K, Mendoza L, Paquette DW, Barrow DA, et al. Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J Periodontol. 2009;80(2):190–201.
6. Burgess S, Lee AM, Saleheen D, Foley CN, Quanil HM. Mendelian randomization to test whether periodontitis is causally associated with stroke, coronary artery disease, or subclinical atherosclerosis. Atherosclerosis. 2020;312:111–117.
7. Liccardo D, Cannavo A, Spagnuolo G, Bencivenga L, Ferrara N, Rengo G, et al. Periodontal Disease: A Risk Factor for Diabetes and Cardiovascular Disease. Int J Mol Sci. 2019;20(6):1414.
8. Roth GA, et al. Global trends of Cardiovascular Disease and its risk factors from 1990 to 2021. Cureus. 2024.
9. Sanz M, Marco Del Castillo A, Jepsen S, Gonzalez-Juanatey JR, D’Aiuto F, Bouchard P, et al. Periodontitis and cardiovascular diseases: Consensus report. J Clin Periodontol. 2020;47(3):268–288.
10. Tran N, et al. Periodontal Disease and Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2026;153:e73-e88.
11. Caton JG, Armitage G, Berglundh T, Chapple ILC, Jepsen S, Kornman KS, et al. A new classification scheme for periodontal and peri-implant diseases and conditions — Introduction and key changes from the 1999 classification. J Clin Periodontol. 2018;45 Suppl 20:S1-S8.
12. Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M, Fine DH, et al. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Clin Periodontol. 2018;45 Suppl 20:S162-S170.
13. Libby P. The changing landscape of atherosclerosis. Nature. 2021;592(7855):524–533.
14. Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868–874.
15. Zhang B, Xie Y, Huang Y, Chen Y, Yin Y, Lu X, et al. The Effects of Porphyromonas gingivalis on Atherosclerosis-Related Cells. Front Immunol. 2021;12:766560.
16. Muñoz Aguilera E, Suvan J, Buti J, Czesnikiewicz-Guzik M, Barbosa Ribeiro A, Orlandi M, et al. Periodontitis is associated with hypertension: a systematic review and meta-analysis. Cardiovasc Res. 2020;116(1):28–39.
17. Meng H, Chen Y. The association between periodontal disease and stroke risk: a systematic review and meta-analysis. J Evid Based Dent Pract. 2025;25(4):102172.
18. Leira Y, Seoane J, Blanco M, Rodríguez-Yáñez M, Treviño M, Quintas-Corredoira A, et al. Association between periodontitis and ischemic stroke: a systematic review and meta-analysis. Eur J Epidemiol. 2017;32(1):43–53.
19. Choe MS, et al. Effect of age and systemic inflammation on the association between severity of periodontitis and blood pressure in periodontitis patients. BMC Oral Health. 2025;25(1):273.
20. Szulc M, et al. Presence of Periodontopathic Bacteria DNA in Atheromatous Plaques from Coronary and Carotid Arteries. Biomed Res Int. 2015;2015:825397.
21. Lockhart PB, et al. Porphyromonas gingivalis is the most abundant species detected in coronary and femoral arteries. J Oral Microbiol. 2017;9(1):127–133.
22. Chou HH, Yumoto H, et al. Porphyromonas gingivalis Fimbria-Dependent Activation of Inflammatory Genes in Human Aortic Endothelial Cells. Infect Immun. 2005;73(8):5367–5378.
23. Lin X, et al. Effects and mechanisms of Porphyromonas gingivalis outer membrane vesicles induced cardiovascular injury. Front Cell Infect Microbiol. 2023.
24. D’Aiuto F, Nibali L, Parkar M, Patel K, Suvan J, Donos N. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial. J Dent Res. 2006.
25. Orlandi M, Graziani F, D’Aiuto F. Periodontal therapy and cardiovascular risk. Periodontol 2000. 2020;83(1):107–124.
26. Tonetti MS, D’Aiuto F, Nibali L, Donald A, Storry C, Parkar M, et al. Treatment of periodontitis and endothelial function. N Engl J Med. 2007;356(9):911–920.
27. Lalla E, Papapanou PN. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nat Rev Endocrinol. 2011;7(12):738–748.
28. Yamazaki K, Ohsawa Y, Yoshie H. Cross-reactivity of GroEL antibodies with human heat shock protein 60 and quantification of pathogens in atherosclerosis. J Periodontol. 2005;76(8):1295–1304.
29. Puzhankara L, Janakiram C, Gutjahr G, Bijukumar SC, Vasthare R, Kedlaya MN, et al. Risk correlates of cardiovascular diseases, diabetes, and periodontal disease. BMC Public Health. 2024.
30. Wang J, et al. Bias analysis of confounding factors between diabetes and periodontitis. J Clin Periodontol. 2024.
31. Chen YT, et al. Periodontal Treatment and the Risks of Cardiovascular Disease in Patients with Type 2 Diabetes: A Retrospective Cohort Study. Intern Med. 2017;56(9):1015–1021.
32. Kocher T, et al. Modifying risk factors for periodontitis and systemic diseases. J Clin Periodontol. 2021.
33. Larsson SC, et al. A Mendelian Randomisation Analysis Reveals No Relationship Between Periodontitis and Coronary Atherosclerosis. Am J Cardiol. 2024.
34. Shi Y, et al. Exploring the shared genetic architecture between periodontitis and cardiovascular disease. BDJ Open. 2026;12(1):28.
35. Beck JD, Elter JR, Heiss G, Couper D, Mauriello SM, Offenbacher S. The Periodontitis and Vascular Events (PAVE) Pilot Study: Adverse Events. J Periodontol. 2008;79(1):90–96.
36. Wu CZ, Yuan YH, Liu HH, et al. Epidemiologic relationship between periodontitis and type 2 diabetes mellitus. J Clin Periodontol. 2020;47(6):702–715.
37. Li X, et al. Biological aging mediates the association between periodontitis and cardiovascular disease: results from a national population study and Mendelian randomization analysis. BMC Public Health. 2024.